0001562180-24-000402.txt : 20240109
0001562180-24-000402.hdr.sgml : 20240109
20240109211724
ACCESSION NUMBER: 0001562180-24-000402
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240105
FILED AS OF DATE: 20240109
DATE AS OF CHANGE: 20240109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lurker Nancy
CENTRAL INDEX KEY: 0001450485
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 24524744
MAIL ADDRESS:
STREET 1: PDI, INC.
STREET 2: 1 ROUTE 17 SOUTH
CITY: SADDLE RIVER
STATE: NJ
ZIP: 07458
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-01-05
false
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001450485
Lurker Nancy
C/O EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET
WATERTOWN
MA
02472
true
true
false
false
Executive Vice Chair
false
Common Stock
2024-01-06
4
M
false
75133.00
0.00
A
193484.00
D
Common Stock
2024-01-06
4
F
false
23043.00
20.40
D
170441.00
D
Restricted Stock Units
0.00
2024-01-05
4
A
false
38000.00
0.00
A
2034-01-05
Common Stock
38000.00
38000.00
D
Stock Option (Right to Buy)
20.40
2024-01-05
4
A
false
77000.00
0.00
A
2034-01-04
Common Stock
77000.00
77000.00
D
Restricted Stock Units
0.00
2024-01-06
4
M
false
75133.00
0.00
D
2033-06-19
Common Stock
75133.00
150267.00
D
No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
The restricted stock units will vest in three ratable annual installments beginning January 5, 2025.
The option to purchase will vest and become exercisable as follows: 25% at January 5th, 2025 and the remainder ratably, on a monthly basis, over the remaining three years.
The restricted stock units vests in three ratable annual installments beginning January 6, 2024.
/s/ Ron Honig, Attorney-in-Fact
2024-01-09